HEADER ANTITUMOR PROTEIN 26-OCT-17 6ETJ TITLE HUMAN PFKFB3 IN COMPLEX WITH KAN0438241 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PFK/FBPASE 3,6PF-2-K/FRU-2,6-P2ASE BRAIN/PLACENTA-TYPE COMPND 5 ISOZYME,RENAL CARCINOMA ANTIGEN NY-REN-56,IPFK-2; COMPND 6 EC: 2.7.1.105,3.1.3.46; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PFKFB3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PDEST14 KEYWDS DNA DAMAGE REPAIR, HOMOLOGOUS RECOMBINATION, GLYCOLYSIS, NUCLEOTIDE KEYWDS 2 METABOLISM, PFKFB3, ANTITUMOR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR N.M.S.GUSTAFSSON,T.LUNDBACK,K.FARNEGARDH,P.GROTH,E.WIITTA,M.JONSSON, AUTHOR 2 K.HALLBERG,R.PENNISI,A.HUGUET NINOU,J.MARTINSSON,C.NORSTROM, AUTHOR 3 J.SCHULTZ,M.ANDERSSON,N.MARKOVA,P.MARTTILA,M.NORIN,T.OLIN,T.HELLEDAY REVDAT 2 29-JUL-20 6ETJ 1 COMPND REMARK HETNAM SITE REVDAT 1 07-NOV-18 6ETJ 0 JRNL AUTH N.M.S.GUSTAFSSON,K.FARNEGARDH,N.BONAGAS,A.H.NINOU,P.GROTH, JRNL AUTH 2 E.WIITA,M.JONSSON,K.HALLBERG,J.LEHTO,R.PENNISI,J.MARTINSSON, JRNL AUTH 3 C.NORSTROM,J.HOLLERS,J.SCHULTZ,M.ANDERSSON,N.MARKOVA, JRNL AUTH 4 P.MARTTILA,B.KIM,M.NORIN,T.OLIN,T.HELLEDAY JRNL TITL TARGETING PFKFB3 RADIOSENSITIZES CANCER CELLS AND SUPPRESSES JRNL TITL 2 HOMOLOGOUS RECOMBINATION. JRNL REF NAT COMMUN V. 9 3872 2018 JRNL REFN ESSN 2041-1723 JRNL PMID 30250201 JRNL DOI 10.1038/S41467-018-06287-X REMARK 2 REMARK 2 RESOLUTION. 2.51 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.51 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.28 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 27596 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1453 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.51 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.58 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1750 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.89 REMARK 3 BIN R VALUE (WORKING SET) : 0.2870 REMARK 3 BIN FREE R VALUE SET COUNT : 96 REMARK 3 BIN FREE R VALUE : 0.3140 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3531 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 75 REMARK 3 SOLVENT ATOMS : 102 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.57 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.15 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.37000 REMARK 3 B22 (A**2) : 1.37000 REMARK 3 B33 (A**2) : -2.06000 REMARK 3 B12 (A**2) : 0.69000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.267 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.221 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.162 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.626 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.919 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3714 ; 0.011 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5041 ; 1.626 ; 1.993 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 440 ; 6.192 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 182 ;37.334 ;23.352 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 663 ;17.482 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 35 ;17.845 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 548 ; 0.097 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2804 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6ETJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1200007236. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-MAR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XSCALE REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29050 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.510 REMARK 200 RESOLUTION RANGE LOW (A) : 34.280 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.128 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.5700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.51 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.26 REMARK 200 R MERGE FOR SHELL (I) : 0.75300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, HEPES, GLYCEROL, PH 7.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+1/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 173.04200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 86.52100 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 129.78150 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 43.26050 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 216.30250 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 173.04200 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 86.52100 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 43.26050 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 129.78150 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 216.30250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 2 0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -43.26050 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 PRO A 1 REMARK 465 LEU A 2 REMARK 465 PRO A 23 REMARK 465 ARG A 24 REMARK 465 SER A 25 REMARK 465 CYS A 26 REMARK 465 GLY A 27 REMARK 465 PRO A 28 REMARK 465 LYS A 29 REMARK 465 LEU A 30 REMARK 465 THR A 31 REMARK 465 ASN A 32 REMARK 465 SER A 445 REMARK 465 GLU A 446 REMARK 465 ASP A 447 REMARK 465 ALA A 448 REMARK 465 LYS A 449 REMARK 465 LYS A 450 REMARK 465 GLY A 451 REMARK 465 PRO A 452 REMARK 465 ASN A 453 REMARK 465 PRO A 454 REMARK 465 LEU A 455 REMARK 465 MET A 456 REMARK 465 ARG A 457 REMARK 465 ARG A 458 REMARK 465 ASN A 459 REMARK 465 SER A 460 REMARK 465 VAL A 461 REMARK 465 THR A 462 REMARK 465 PRO A 463 REMARK 465 LEU A 464 REMARK 465 ALA A 465 REMARK 465 SER A 466 REMARK 465 PRO A 467 REMARK 465 GLU A 468 REMARK 465 PRO A 469 REMARK 465 THR A 470 REMARK 465 LYS A 471 REMARK 465 LYS A 472 REMARK 465 PRO A 473 REMARK 465 ARG A 474 REMARK 465 ILE A 475 REMARK 465 ASN A 476 REMARK 465 SER A 477 REMARK 465 PHE A 478 REMARK 465 GLU A 479 REMARK 465 GLU A 480 REMARK 465 HIS A 481 REMARK 465 VAL A 482 REMARK 465 ALA A 483 REMARK 465 SER A 484 REMARK 465 THR A 485 REMARK 465 SER A 486 REMARK 465 ALA A 487 REMARK 465 ALA A 488 REMARK 465 LEU A 489 REMARK 465 PRO A 490 REMARK 465 SER A 491 REMARK 465 CYS A 492 REMARK 465 LEU A 493 REMARK 465 PRO A 494 REMARK 465 PRO A 495 REMARK 465 GLU A 496 REMARK 465 VAL A 497 REMARK 465 PRO A 498 REMARK 465 THR A 499 REMARK 465 GLN A 500 REMARK 465 LEU A 501 REMARK 465 PRO A 502 REMARK 465 GLY A 503 REMARK 465 GLN A 504 REMARK 465 ASN A 505 REMARK 465 MET A 506 REMARK 465 LYS A 507 REMARK 465 GLY A 508 REMARK 465 SER A 509 REMARK 465 ARG A 510 REMARK 465 SER A 511 REMARK 465 SER A 512 REMARK 465 ALA A 513 REMARK 465 ASP A 514 REMARK 465 SER A 515 REMARK 465 SER A 516 REMARK 465 ARG A 517 REMARK 465 LYS A 518 REMARK 465 HIS A 519 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TRP A 13 CE2 TRP A 13 CD2 0.076 REMARK 500 HIS A 138 CG HIS A 138 CD2 0.055 REMARK 500 HIS A 387 CG HIS A 387 CD2 0.061 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 79 -73.19 -50.24 REMARK 500 SER A 82 -68.42 -92.31 REMARK 500 ASP A 176 69.39 -107.66 REMARK 500 LYS A 204 -88.50 -116.28 REMARK 500 ARG A 207 -29.88 -33.95 REMARK 500 ASP A 267 52.64 -143.31 REMARK 500 ASN A 289 73.18 42.28 REMARK 500 ARG A 311 46.67 39.95 REMARK 500 ASP A 350 69.31 -153.57 REMARK 500 GLU A 380 -100.68 -119.56 REMARK 500 CYS A 386 -132.30 -143.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER A 21 LEU A 22 148.46 REMARK 500 REMARK 500 REMARK: NULL DBREF 6ETJ A 0 519 UNP Q16875 F263_HUMAN 1 520 SEQRES 1 A 520 MET PRO LEU GLU LEU THR GLN SER ARG VAL GLN LYS ILE SEQRES 2 A 520 TRP VAL PRO VAL ASP HIS ARG PRO SER LEU PRO ARG SER SEQRES 3 A 520 CYS GLY PRO LYS LEU THR ASN SER PRO THR VAL ILE VAL SEQRES 4 A 520 MET VAL GLY LEU PRO ALA ARG GLY LYS THR TYR ILE SER SEQRES 5 A 520 LYS LYS LEU THR ARG TYR LEU ASN TRP ILE GLY VAL PRO SEQRES 6 A 520 THR LYS VAL PHE ASN VAL GLY GLU TYR ARG ARG GLU ALA SEQRES 7 A 520 VAL LYS GLN TYR SER SER TYR ASN PHE PHE ARG PRO ASP SEQRES 8 A 520 ASN GLU GLU ALA MET LYS VAL ARG LYS GLN CYS ALA LEU SEQRES 9 A 520 ALA ALA LEU ARG ASP VAL LYS SER TYR LEU ALA LYS GLU SEQRES 10 A 520 GLY GLY GLN ILE ALA VAL PHE ASP ALA THR ASN THR THR SEQRES 11 A 520 ARG GLU ARG ARG HIS MET ILE LEU HIS PHE ALA LYS GLU SEQRES 12 A 520 ASN ASP PHE LYS ALA PHE PHE ILE GLU SER VAL CYS ASP SEQRES 13 A 520 ASP PRO THR VAL VAL ALA SER ASN ILE MET GLU VAL LYS SEQRES 14 A 520 ILE SER SER PRO ASP TYR LYS ASP CYS ASN SER ALA GLU SEQRES 15 A 520 ALA MET ASP ASP PHE MET LYS ARG ILE SER CYS TYR GLU SEQRES 16 A 520 ALA SER TYR GLN PRO LEU ASP PRO ASP LYS CYS ASP ARG SEQRES 17 A 520 ASP LEU SER LEU ILE LYS VAL ILE ASP VAL GLY ARG ARG SEQRES 18 A 520 PHE LEU VAL ASN ARG VAL GLN ASP HIS ILE GLN SER ARG SEQRES 19 A 520 ILE VAL TYR TYR LEU MET ASN ILE HIS VAL GLN PRO ARG SEQRES 20 A 520 THR ILE TYR LEU CYS ARG NEP GLY GLU ASN GLU HIS ASN SEQRES 21 A 520 LEU GLN GLY ARG ILE GLY GLY ASP SER GLY LEU SER SER SEQRES 22 A 520 ARG GLY LYS LYS PHE ALA SER ALA LEU SER LYS PHE VAL SEQRES 23 A 520 GLU GLU GLN ASN LEU LYS ASP LEU ARG VAL TRP THR SER SEQRES 24 A 520 GLN LEU LYS SER THR ILE GLN THR ALA GLU ALA LEU ARG SEQRES 25 A 520 LEU PRO TYR GLU GLN TRP LYS ALA LEU ASN GLU ILE ASP SEQRES 26 A 520 ALA GLY VAL CYS GLU GLU LEU THR TYR GLU GLU ILE ARG SEQRES 27 A 520 ASP THR TYR PRO GLU GLU TYR ALA LEU ARG GLU GLN ASP SEQRES 28 A 520 LYS TYR TYR TYR ARG TYR PRO THR GLY GLU SER TYR GLN SEQRES 29 A 520 ASP LEU VAL GLN ARG LEU GLU PRO VAL ILE MET GLU LEU SEQRES 30 A 520 GLU ARG GLN GLU ASN VAL LEU VAL ILE CYS HIS GLN ALA SEQRES 31 A 520 VAL LEU ARG CYS LEU LEU ALA TYR PHE LEU ASP LYS SER SEQRES 32 A 520 ALA GLU GLU MET PRO TYR LEU LYS CYS PRO LEU HIS THR SEQRES 33 A 520 VAL LEU LYS LEU THR PRO VAL ALA TYR GLY CYS ARG VAL SEQRES 34 A 520 GLU SER ILE TYR LEU ASN VAL GLU SER VAL CYS THR HIS SEQRES 35 A 520 ARG GLU ARG SER GLU ASP ALA LYS LYS GLY PRO ASN PRO SEQRES 36 A 520 LEU MET ARG ARG ASN SER VAL THR PRO LEU ALA SER PRO SEQRES 37 A 520 GLU PRO THR LYS LYS PRO ARG ILE ASN SER PHE GLU GLU SEQRES 38 A 520 HIS VAL ALA SER THR SER ALA ALA LEU PRO SER CYS LEU SEQRES 39 A 520 PRO PRO GLU VAL PRO THR GLN LEU PRO GLY GLN ASN MET SEQRES 40 A 520 LYS GLY SER ARG SER SER ALA ASP SER SER ARG LYS HIS MODRES 6ETJ NEP A 253 HIS MODIFIED RESIDUE HET NEP A 253 14 HET DMS A 601 4 HET F6P A 602 16 HET BWW A 603 28 HET ADP A 604 27 HETNAM NEP N1-PHOSPHONOHISTIDINE HETNAM DMS DIMETHYL SULFOXIDE HETNAM F6P 6-O-PHOSPHONO-BETA-D-FRUCTOFURANOSE HETNAM BWW 4-[[3-(5-FLUORANYL-2-OXIDANYL-PHENYL) HETNAM 2 BWW PHENYL]SULFONYLAMINO]-2-OXIDANYL-BENZOIC ACID HETNAM ADP ADENOSINE-5'-DIPHOSPHATE FORMUL 1 NEP C6 H10 N3 O5 P FORMUL 2 DMS C2 H6 O S FORMUL 3 F6P C6 H13 O9 P FORMUL 4 BWW C19 H14 F N O6 S FORMUL 5 ADP C10 H15 N5 O10 P2 FORMUL 6 HOH *102(H2 O) HELIX 1 AA1 GLY A 46 GLY A 62 1 17 HELIX 2 AA2 VAL A 70 VAL A 78 1 9 HELIX 3 AA3 SER A 83 ARG A 88 5 6 HELIX 4 AA4 ASN A 91 GLU A 116 1 26 HELIX 5 AA5 THR A 129 ASN A 143 1 15 HELIX 6 AA6 ASP A 156 LYS A 168 1 13 HELIX 7 AA7 SER A 171 LYS A 175 5 5 HELIX 8 AA8 ASN A 178 ALA A 195 1 18 HELIX 9 AA9 ASP A 228 ILE A 241 1 14 HELIX 10 AB1 ASN A 256 GLN A 261 1 6 HELIX 11 AB2 SER A 271 ASN A 289 1 19 HELIX 12 AB3 LEU A 300 ALA A 309 1 10 HELIX 13 AB4 LYS A 318 ASN A 321 5 4 HELIX 14 AB5 ALA A 325 GLU A 329 5 5 HELIX 15 AB6 THR A 332 TYR A 340 1 9 HELIX 16 AB7 TYR A 340 ASP A 350 1 11 HELIX 17 AB8 SER A 361 GLN A 379 1 19 HELIX 18 AB9 HIS A 387 ASP A 400 1 14 HELIX 19 AC1 GLU A 405 LEU A 409 5 5 SHEET 1 AA1 2 LEU A 4 GLN A 6 0 SHEET 2 AA1 2 TRP A 13 PRO A 15 -1 O VAL A 14 N THR A 5 SHEET 1 AA2 6 THR A 65 ASN A 69 0 SHEET 2 AA2 6 ILE A 120 ASP A 124 1 O VAL A 122 N PHE A 68 SHEET 3 AA2 6 THR A 35 VAL A 40 1 N ILE A 37 O ALA A 121 SHEET 4 AA2 6 LYS A 146 SER A 152 1 O PHE A 148 N VAL A 38 SHEET 5 AA2 6 SER A 210 ILE A 215 1 O VAL A 214 N GLU A 151 SHEET 6 AA2 6 ARG A 220 ASN A 224 -1 O ARG A 220 N ILE A 215 SHEET 1 AA3 6 TYR A 314 GLN A 316 0 SHEET 2 AA3 6 ARG A 294 THR A 297 1 N THR A 297 O GLU A 315 SHEET 3 AA3 6 VAL A 382 CYS A 386 1 O LEU A 383 N TRP A 296 SHEET 4 AA3 6 ILE A 248 ARG A 252 1 N TYR A 249 O VAL A 384 SHEET 5 AA3 6 THR A 415 VAL A 422 -1 O LEU A 419 N ILE A 248 SHEET 6 AA3 6 GLY A 425 TYR A 432 -1 O GLU A 429 N LYS A 418 LINK C ARG A 252 N NEP A 253 1555 1555 1.33 LINK C NEP A 253 N GLY A 254 1555 1555 1.34 CRYST1 103.774 103.774 259.563 90.00 90.00 120.00 P 65 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009636 0.005564 0.000000 0.00000 SCALE2 0.000000 0.011127 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003853 0.00000